Dermatology 2013

Notes: Taheri, Arash

Yentzer, Brad A

Feldman, Steven R

eng

Review

England

ISBS

2013/03/27 06:00

Skin Res Technol. 2013 Nov;19(4):394-7. doi: 10.1111/srt.12058. Epub 2013 Mar 25.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23528235

Author Address: Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

 

 

Reference Type:  Journal Article

Record Number: 4573Author: Taieb, A., Alomar, A., Bohm, M., Dell’anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T., Leone, G., Moretti, S., Nieuweboer-Krobotova, L., Olsson, M. J., Parsad, D., Passeron, T., Tanew, A., van der Veen, W., van Geel, N., Whitton, M., Wolkerstorfer, A., Picardo, M., Vitiligo European Task, Force, European Academy of, Dermatology, Venereology and Union Europe enne des Me decins Spe, cialistes

Year: 2013

Title: Guidelines for the management of vitiligo: the European Dermatology Forum consensus

Journal: Br J Dermatol

Volume: 168

Issue: 1

Pages: 5-19

Date: Jan

Short Title: Guidelines for the management of vitiligo: the European Dermatology Forum consensus

Alternate Journal: The British journal of dermatology

ISSN: 1365-2133 (Electronic)

0007-0963 (Linking)

DOI: 10.1111/j.1365-2133.2012.11197.x

Accession Number: 22860621

Keywords: Administration, Cutaneous

Administration, Oral

Adrenal Cortex Hormones/administration & dosage

Antioxidants/therapeutic use

Calcineurin/antagonists & inhibitors

Checklist

Combined Modality Therapy

Dermatologic Agents/therapeutic use

Humans

Immunosuppressive Agents/therapeutic use

Phototherapy/methods

Skin Lightening Preparations/therapeutic use

Steroids/administration & dosage

Treatment Outcome

Vitiligo/diagnosis/*therapy

Abstract: The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. This guideline for the treatment of segmental and nonsegmental vitiligo has been developed by the members of the Vitiligo European Task Force and other colleagues. It summarizes evidence-based and expert-based recommendations (S1 level).

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295